1. BIOLASE introduces a new laser protocol for periodontal treatment. 2. A demonstration will occur at the AAP 2025 forum in Toronto. 3. The new technique promises enhanced patient comfort and predictability. 4. Live demos of the Waterlase iPlus laser will attract attention. 5. BIOLASE aims to lead in dental laser technology advancements.
The introduction of a novel periodontal treatment could expedite adoption by dental professionals. Historical success of past innovations in the sector correlates with stock growth.
The innovative product could significantly improve market performance in a growing sector, making it likely to influence investor sentiment positively.
Enhanced product offerings may lead to sustained market share growth over time, similar to trends seen with advanced dental technologies from competitors.
TORONTO, Oct. 14, 2025 /PRNewswire/ -- BIOLASE, the global leader in dental laser technology, will present a major advancement in periodontal care during the American Academy of Periodontology (AAP) 2025 Corporate Forum in Toronto, October 15–18.
Philip Kang, DDS, will lead a featured session titled "Redefining Periodontitis Treatment: A Novel YSGG Laser-Resective Protocol for Predictable Pocket Elimination" on Wednesday, October 15 at 2:05 PM (Room 709, MTCC).
The presentation introduces an innovative Er,Cr:YSGG laser-assisted surgical protocol designed to standardize resective periodontitis treatment, achieving greater predictability, efficiency, and patient comfort. Attendees will gain insights into how the new technique enables:
This novel protocol leverages YSGG laser technology to deliver consistent, long-term periodontal health—and positions the laser as an essential tool in modern periodontics.
Hands-On Demos and Giveaways at BIOLASE Booth #1004
BIOLASE invites attendees to visit Booth #1004 for live demonstrations of the Waterlase iPlus Premier Edition™, the company's most advanced all-tissue laser. Visitors who test drive the Waterlase iPlus will receive a complimentary BIOLASE travel mug.
The Waterlase iPlus is supported by a landmark blind study designed by The McGuire Institute™ and published in the Journal of Periodontology, confirming:
"BIOLASE is committed to advancing the science and precision of laser dentistry to support better patient care worldwide," said Dr. Kwang Bum Park, CEO of BIOLASE. "Our presence at AAP 2025 demonstrates our continued dedication to innovation that empowers clinicians and transforms treatment outcomes."
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE MG LLC.
For updates and information on BIOLASE and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Instagram at www.instagram.com/biolase_official, and LinkedIn at www.linkedin.com/company/biolase/.
About BIOLASE
BIOLASE is the world's leading innovator in dental laser technology, manufacturing high-performance laser systems that advance dentistry and improve patient experiences. With a legacy of over three decades, BIOLASE continues to define the future of minimally invasive dentistry.
Media Contact
Denise Arterberry
Marketing Manager, BIOLASE
darterberry@biolase.com
949.226.8190
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-showcases-breakthrough-ysgg-laser-protocol-for-predictable-periodontitis-treatment-at-aap-2025-302582930.html
SOURCE BIOLASE MG LLC